<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2709-7927</journal-id>
<journal-title><![CDATA[Acta Médica del Centro]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd centro]]></abbrev-journal-title>
<issn>2709-7927</issn>
<publisher>
<publisher-name><![CDATA[Hospital Provincial Clínico Quirúrgico Universitario Arnaldo Milián Castro]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2709-79272021000300413</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[El COVID-19 en pacientes pediátricos atendidos en la Provincia de Villa Clara]]></article-title>
<article-title xml:lang="en"><![CDATA[The COVID-19 in pediatric patients that were treated in Villa Clara Province]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Marrero]]></surname>
<given-names><![CDATA[Fidel Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Sandeliz]]></surname>
<given-names><![CDATA[Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[De la Torre Pérez]]></surname>
<given-names><![CDATA[Juan Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López González]]></surname>
<given-names><![CDATA[Lissette del Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Machado Díaz]]></surname>
<given-names><![CDATA[Marbin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Provincial Pediátrico Universitario &#8220;José Luis Miranda&#8221;  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Provincial Materno-Infantil Universitario &#8220;Piti Fajardo&#8221;  ]]></institution>
<addr-line><![CDATA[Güines Mayabeque]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Pediátrico Universitario &#8220;Juan Manuel Márquez&#8221;  ]]></institution>
<addr-line><![CDATA[Marianao La Habana]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2021</year>
</pub-date>
<volume>15</volume>
<numero>3</numero>
<fpage>413</fpage>
<lpage>424</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2709-79272021000300413&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2709-79272021000300413&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2709-79272021000300413&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el coronavirus 2019 en niños, globalmente, no presenta una elevada casuística y se caracteriza por presentar un amplio espectro clínico; datos aportados por estudios realizados en China y otros países reflejan que la evolución de la enfermedad es menos severa en estos que en los adultos.  Objetivo:  describir los aspectos clínicos, de laboratorio y el tratamiento del coronavirus 2019 en la población pediátrica atendida.  Métodos:  se realizó un estudio descriptivo transversal en 43 pacientes de la Provincia de Villa Clara diagnosticados con la enfermedad desde marzo hasta octubre de 2020; fueron seleccionados mediante muestreo no probabilístico.  Resultados:  fueron afectados un total de 43 niños, predominó el grupo de edad de mayores de 15 años, 20 niños cursaron la enfermedad de forma asintomática y el resto presentó síntomas leves. Se destacaron las manifestaciones cutáneas y los síntomas respiratorios ligeros. En los exámenes de laboratorio a las 72 horas 17 pacientes presentaron leucopenia ligera. El patrón radiológico pulmonar fue normal excepto en dos niños. El tratamiento se aplicó a todos según el protocolo vigente (kaletra, cloroquina e interferón) y mostró excelentes resultados.  Conclusiones:  el diagnóstico clínico favoreció registrar una mayor incidencia de la enfermedad en los pacientes mayores de 15 años, predominaron los casos asintomáticos y los enfermos desarrollaron síntomas leves de la enfermedad, la mayoría presentó valores de laboratorio y rayos X de tórax normales, el tratamiento se basó en la triple terapia según el protocolo de actuación cubano en ese momento.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  the coronavirus disease 2019 in children does not present a high casuistry globally and it is characterized by presenting a wide clinical spectrum. The evolution of the disease is less severe in kids than in adults according to the data which was provided by some studies in China and other countries.  Objective:  to describe the clinical aspects, the laboratory one and the treatment of COVID-19 in the pediatric population that was treated.  Methods:  a descriptive cross-sectional study from Villa Clara Province was carried out in 43 patients that were diagnosed with COVID-19 from March to October 2020, the group of people was selected by non-probabilistic sampling.  Results:  a total of 43 children were affected, the older than 15 years had more predomination, 20 children had the disease asymptomatically and the rest presented mild symptoms. Cutaneous manifestations and mild respiratory symptoms were highlighted. 17 patients presented mild leukopenia in the laboratory tests at 72 hours, the pulmonary radiological pattern was normal except in 2 children. The treatment was applied to everybody according to the actual protocol (kaletra, chloroquine and interferon) and it showed excellent results.  Conclusions:  the clinical diagnosis favored to register a higher incidence of the disease in the patients older than 15 years, the asymptomatic cases predominated and the patients developed mild symptoms of the disease, the majority presented normal laboratory values and chest X-rays, the treatment was based on triple therapy according to the Cuban action protocol at that time.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[pacientes pediátricos]]></kwd>
<kwd lng="en"><![CDATA[SARS-CoV-2]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[pediatric patients]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nieto Caraveo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El coronavirus y la emergencia de nuevas infecciones]]></article-title>
<source><![CDATA[Univ Potosinos]]></source>
<year>2020</year>
<volume>16</volume>
<numero>245</numero>
<issue>245</issue>
<page-range>4-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zou]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ruan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SARS-CoV-2 viral load in upper respiratory specimens of infected patients]]></article-title>
<source><![CDATA[N England J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1177-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>OMS</collab>
<source><![CDATA[COVID-19 Weekly Epidemiological Update - 23 February 2021]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Parte de cierre del día 19 de febrero a las 12 de la noche]]></source>
<year>2021</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<collab>CDC COVID-19 Response Team</collab>
<article-title xml:lang=""><![CDATA[Coronavirus Disease 2019 in Children -United States, February 12-April 2, 2020]]></article-title>
<source><![CDATA[Morb Mortal Wkly Rep]]></source>
<year>2020</year>
<volume>69</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>422-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santana Espinosa]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Lauzerique]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Torres Esperón]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Castro Pacheco]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
</person-group>
<source><![CDATA[Contexto sanitario de niños y adolescentes infestados por la COVID-19 en zonas geográficas seleccionadas. Estudio entre marzo y mayo 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Escuela Nacional de Salud Pública de Cuba]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Atamari Anahui]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Nina]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Condori Huaraka]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[NuñezPaucar]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ordoñez Linares]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de la enfermedad por coronavirus 2019 (COVID-19) en niños y adolescentes en países de América Latina y El Caribe: estudio descriptivo]]></article-title>
<source><![CDATA[Medwave]]></source>
<year>2020</year>
<volume>20</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbosa León]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[No subestimemos el peligro que significa la COVID-19 para los niños]]></source>
<year>2020</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Granma]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>Asociación Médica Mundial</collab>
<source><![CDATA[Declaración de Helsinki de la AMM -Principios éticos para las investigaciones médicas en seres humanos]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Ferney-Voltaire, Francia ]]></publisher-loc>
<publisher-name><![CDATA[AMM]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Centro de Coordinación de Alertas y Emergencias Sanitarias</collab>
<source><![CDATA[Información científica-técnica. Enfermedad por coronavirus, COVID-19]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[CCAES]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[García López-Hortelano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carlos Vicente]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez Martínez]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones sobre el manejo clínico de la infección por el "nuevo coronavirus" SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP)]]></article-title>
<source><![CDATA[AnPediatr (Barc)]]></source>
<year>2020</year>
<volume>92</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dong]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Qu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gong]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
<volume>39</volume>
<numero>10223</numero>
<issue>10223</issue>
<page-range>507-13</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Centro Nacional de Epidemiología, Instituto de Salud Carlos III</collab>
<source><![CDATA[Informe sobre la situación de COVID-19 en España. Informe COVID-19 No.14, 24 de marzo de 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Centro Nacional de Epidemiología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuk-Woo Chan J]]></surname>
<given-names><![CDATA[Yuan S]]></given-names>
</name>
<name>
<surname><![CDATA[Kin-HahgK]]></surname>
<given-names><![CDATA[Kai-Wang To K]]></given-names>
</name>
<name>
<surname><![CDATA[Chu H]]></surname>
<given-names><![CDATA[Yang J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2020</year>
<volume>395</volume>
<numero>10223</numero>
<issue>10223</issue>
<page-range>514-23</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Narros]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestaciones dermatológicas del Covid-19. Presentación de dos casos]]></article-title>
<source><![CDATA[Ozone Ther Glob J]]></source>
<year>2020</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-25</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qilin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Xiuli]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Geqing]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Heng-Gui]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fenghua]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zhi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study]]></article-title>
<source><![CDATA[EClinicalMedicine]]></source>
<year>2020</year>
<volume>23</volume>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[SánchezVera]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Saavedra Hernández]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hidalgo Mesa]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Aguila López]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abreu Gutiérrez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera González]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parámetros de laboratorio clínico en pacientes con la COVID-19]]></article-title>
<source><![CDATA[Rev Cub Med Mil]]></source>
<year>2021</year>
<volume>50</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González Tabares]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta González]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Oliva Villa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Reyes]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Cabeza Echevarría]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictores de mal pronóstico en pacientes con la COVID-19]]></article-title>
<source><![CDATA[Rev Cub Med Mil]]></source>
<year>2020</year>
<volume>49</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acosta Torres]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Cutiño]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Prieto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Morales González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 en pediatría: aspectos clínicos, epidemiológicos, inmunopatogenia, diágnóstico y tratamiento]]></article-title>
<source><![CDATA[Rev Cubana Pediatr]]></source>
<year>2020</year>
<volume>92</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<collab>European Commision</collab>
<article-title xml:lang=""><![CDATA[Anexo I Ficha técnica o resumen de las características del producto. Kaletra 133,3 mg/33,3 mg cápsulas blandas lopinavir/ritonavir]]></article-title>
<source><![CDATA[Public Health - Union Register of medical products]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Bruselas ]]></publisher-loc>
<publisher-name><![CDATA[European Commision]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrera-Lasso Regás]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dordal Culla]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Lleonart Bellfill]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS-CoV-2]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2020</year>
<volume>155</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>448-53</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez Tejeda]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dieguez Guach]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Abreu]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alternativas terapéuticas para el manejo de la COVID-19]]></article-title>
<source><![CDATA[Rev Haban Cienc Méd]]></source>
<year>2020</year>
<volume>19</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
